You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for New Drug Application (NDA): 210933


✉ Email this page to a colleague

« Back to Dashboard


NDA 210933 describes EYSUVIS, which is a drug marketed by Alcon Labs Inc and is included in one NDA. It is available from one supplier. There are sixteen patents protecting this drug. Additional details are available on the EYSUVIS profile page.

The generic ingredient in EYSUVIS is loteprednol etabonate. There are ten drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the loteprednol etabonate profile page.
Summary for 210933
Tradename:EYSUVIS
Applicant:Alcon Labs Inc
Ingredient:loteprednol etabonate
Patents:16
Formulation / Manufacturing:see details
Pharmacology for NDA: 210933
Medical Subject Heading (MeSH) Categories for 210933
Suppliers and Packaging for NDA: 210933
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EYSUVIS loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 210933 NDA ALCON LABORATORIES, INC. 71571-333 71571-333-01 1 BOTTLE, DROPPER in 1 CARTON (71571-333-01) / 1 mL in 1 BOTTLE, DROPPER
EYSUVIS loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 210933 NDA ALCON LABORATORIES, INC. 71571-333 71571-333-24 2.4 mL in 1 BOTTLE, DROPPER (71571-333-24)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION/DROPS;OPHTHALMICStrength0.25%
Approval Date:Oct 26, 2020TE:RLD:Yes
Patent:⤷  Try a TrialPatent Expiration:May 3, 2033Product Flag?YSubstance Flag?Delist Request?
Patented Use:A METHOD FOR DELIVERING A PHARMACEUTICAL AGENT ACROSS A MUCOSAL BARRIER
Patent:⤷  Try a TrialPatent Expiration:May 3, 2033Product Flag?YSubstance Flag?Delist Request?
Patent:⤷  Try a TrialPatent Expiration:May 3, 2033Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.